Related Experiment Video
Updated: Sep 22, 2025

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Patient-reported outcomes and medical device evaluation: from conception to implementation.
Christina M Webber1, Brittany Caldwell1, Fraser D Bocell1
1Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Patient-reported outcomes (PROs) are crucial for medical device evaluation and healthcare decisions. Multi-stakeholder collaboration ensures PRO instruments are fit-for-purpose and minimally burdensome for patients.
Area of Science:
- Medical Device Evaluation
- Patient-Reported Outcomes (PROs)
- Healthcare Ecosystem Integration
Background:
- Patient-reported outcomes (PROs) data hold significant implications for clinical investigations, medical device evaluation, patient care, and reimbursement strategies.
- The U.S. Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) convened a public meeting to discuss the application of PROs throughout the total product lifecycle of medical devices.
- Discussions focused on methods for developing and modifying PRO instruments to ensure they are fit-for-purpose for various applications.
Discussion:
- The integration of patient-reported outcomes (PROs) into clinical care, medical device development, regulatory processes, and reimbursement decisions was a central theme.
- Existing PRO instruments can be utilized if appropriate for the intended context of use.
- Modifications to existing instruments or the development of novel PRO instruments may be necessary to accurately capture patient experiences in new contexts or populations.
Key Insights:
- Fit-for-purpose patient-reported outcome (PRO) instruments are essential for incorporating the patient perspective into healthcare.
- Multi-stakeholder collaborations, including patients, streamline the development and modification of PRO instruments.
- Ensuring PRO instruments are fit-for-purpose is critical for regulatory and reimbursement decision-making.
Outlook:
- Continued collaboration among researchers, clinicians, patients, regulators, and payers is vital for advancing the use of PROs in healthcare.
- Efficient and patient-centric approaches are necessary for integrating PRO data across the healthcare ecosystem.
- Future opportunities lie in leveraging PRO data more broadly to enhance medical product development and patient care.
More Related Videos
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
10:42Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
Published on: June 17, 2022
Related Concept Videos
Nursing Evaluation
Clinical Trials: Overview
Preclinical Development: Overview
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Clinical Trials
There are four phases in a clinical trial. A phase one...